| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2024-02-07 | MOORE JOHN R | General Counsel | Sale+OE | 17,993 | $20.00 | $359,863.60 | -100% | → |
| 2024-02-07 | Derakhshan Behrad | Chief Business Officer | Sale+OE | 600 | $20.00 | $12,000.00 | -7.9% | → |
| 2024-01-23 | Carruthers R Michael | Chief Financial Officer | Sale+OE | 90,000 | $15.78 | $1,419,759.00 | -75.6% | → |
| 2024-01-23 | Thompson Peter A. | - | Buy | 454,545 | $11.00 | $4,999,995.00 | +3.3% | → |
| 2024-01-23 | ORBIMED ADVISORS LLC | - | Buy | 454,545 | $11.00 | $4,999,995.00 | +3.3% | → |
| 2023-12-27 | MOORE JOHN R | General Counsel | Sell | 8,497 | $10.50 | $89,218.50 | -100% | → |
| 2023-12-26 | Fox Jonathan C | - | Buy | 10,857 | $9.30 | $100,958.16 | New | → |
| 2023-12-26 | Russell Alan J | Chief Scientific Officer | Sell | 172,585 | $9.33 | $1,610,097.24 | -98.0% | → |
| 2023-05-02 | Derakhshan Behrad | Chief Business Officer | Sale+OE | 1,747 | $8.90 | $15,556.86 | -19.9% | → |
| 2023-05-02 | MOORE JOHN R | General Counsel | Sale+OE | 1,897 | $8.90 | $16,892.60 | -22.4% | → |
| 2023-05-02 | Russell Alan J | Chief Scientific Officer | Sale+OE | 1,602 | $8.90 | $14,265.65 | -0.9% | → |
| 2023-05-02 | Donovan Joanne M. | CMO | Sale+OE | 3,254 | $8.90 | $28,976.54 | -24.6% | → |
| 2023-05-02 | KOCH KEVIN | President and CEO | Sale+OE | 3,203 | $8.90 | $28,522.39 | -30.8% | → |
| 2023-05-02 | Carruthers R Michael | Chief Financial Officer | Sale+OE | 1,336 | $8.90 | $11,896.95 | -7.7% | → |
| 2022-10-03 | MOORE JOHN R | General Counsel | Sale+OE | 4,730 | $9.76 | $46,154.87 | -61.2% | → |
| 2022-09-16 | Thompson Peter A. | - | Buy | 484,496 | $10.32 | $4,999,998.72 | +3.6% | → |
| 2022-09-16 | ORBIMED ADVISORS LLC | - | Buy | 484,496 | $10.32 | $4,999,998.72 | +3.6% | → |
| 2022-09-14 | Novo Holdings A/S | 10% Owner | Buy | 484,496 | $10.32 | $4,999,998.72 | +8.7% | → |
| 2022-09-06 | MOORE JOHN R | General Counsel | Sale+OE | 4,730 | $10.91 | $51,597.72 | -36.2% | → |
| 2022-08-03 | MOORE JOHN R | General Counsel | Sale+OE | 9,232 | $9.31 | $85,921.30 | -75.5% | → |
| 2022-07-06 | MOORE JOHN R | General Counsel | Sale+OE | 9,232 | $8.37 | $77,256.36 | -60.6% | → |
| 2022-06-21 | MOORE JOHN R | General Counsel | Sale+OE | 67,927 | $6.83 | $463,934.93 | -88.3% | → |
| 2022-06-15 | MOORE JOHN R | General Counsel | Sale+OE | 26,381 | $6.08 | $160,456.51 | -46.7% | → |
| 2022-06-10 | MOORE JOHN R | General Counsel | Sale+OE | 27,306 | $6.44 | $175,878.36 | -75.2% | → |
| 2022-06-07 | MOORE JOHN R | General Counsel | Sale+OE | 47,287 | $6.26 | $295,984.99 | -79.8% | → |
| 2022-05-18 | ORBIMED ADVISORS LLC | - | Buy | 138,000 | $7.21 | $994,980.00 | +1.0% | → |
| 2022-05-18 | Thompson Peter A. | - | Buy | 138,000 | $7.21 | $994,980.00 | +1.0% | → |
| 2022-05-16 | MOORE JOHN R | General Counsel | Sell | 10,800 | $7.42 | $80,145.72 | -78.3% | → |
| 2021-11-15 | Russell Alan J | Chief Scientific Officer | Sell | 479 | $19.11 | $9,155.40 | -92.6% | → |
| 2021-11-12 | Russell Alan J | Chief Scientific Officer | Sell | 69,740 | $19.91 | $1,388,787.60 | -28.7% | → |
| 2021-11-08 | Russell Alan J | Chief Scientific Officer | Sell | 9,017 | $20.16 | $181,824.20 | -11.4% | → |